Gilead, Seattle
Gilead lays off 72 workers in Seattle, plans to shutter R&D support site
Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh its cell therapy subsidiary. | Gilead will lay off 72 staffers in Seattle, the company confirmed Thursday.
COVID drugmaker to close Seattle office, laying off 72 workers
The Washington State Employment Security Department said in the filing that 72 employees will be laid off on Jan. 17. A Gilead spokesperson said in an emailed statement that some teams will be moved to other offices outside of Seattle.
Biotech giant Gilead Sciences to close its Seattle office, lay off employees
Global biopharmaceutical company Gilead Sciences Inc. (Nasdaq: GILD) is closing its office in Seattle and laying off 72 employees, according to a Washington state Worker Adjustment and Retraining Notification filed on Wednesday.
Wolfe Research initiated coverage of Gilead (GILD) with an Outperform rating and $110 price target Gilead’s bread and butter has been ...
More cuts are hitting Gilead’s cell therapy wing, including the closure of a Philadelphia office. A small number of ...
Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.
Zacks.com on MSN15h
Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a BetWhen deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often ...
Hosted on MSN15h
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should KnowGilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Wolfe Research initiated coverage of Gilead (GILD) with an Outperform rating and $110 price target Published first on TheFly – the ...
(This story was updated to accurately reflect the most current information.) OBETZ — Mount Gilead left nothing to chance ...
“Home” is part of the Robinson’s Gilead-set series. The novel takes place in a remote fictional rural Iowan town in 1956, ...
(RTTNews) - Gilead Sciences Inc. (GILD) announced the pricing of senior unsecured notes in an aggregate principal amount of $3.5 billion, in an underwritten, registered public offering, consisting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback